超敏难辨梭菌毒素检测与GDH-毒素EIA联合细胞毒素检测算法高度一致
本研究用211份残余粪便样本比较Singulex Clarity难辨梭菌毒素A/B超敏免疫分析与基于GDH-毒素EIA并以CCNA仲裁的多步算法的性能。Clarity与GDH-/毒素-样本阴性一致率96.2%,与GDH+/毒素+样本阳性一致率100%,与GDH+/毒素-/CCNA-样本一致率95.3%。该自动化检测可能为CDI诊断提供准确的独立方案。
要点
- Clarity与GDH-/毒素-样本阴性一致率96.2%,与GDH+/毒素+样本阳性一致率100%。
- Clarity与GDH+/毒素-/CCNA-样本一致率95.3%,与CCNA+样本一致率61.5%。
- Clarity可能作为CDI诊断的独立自动化方案,但需进一步前瞻性临床研究。
核心结论
- Singulex Clarity C. diff toxins A/B检测与采用GDH-毒素EIA及CCNA的检测算法高度一致。
- 该新型自动化检测可能为CDI诊断提供准确的独立解决方案。
- 需进一步前瞻性临床研究验证。
研究设计与样本
- 用211份残余去标识粪便样本评估Clarity检测性能,样本在-80°C储存后检测。
- 对照算法为GDH-毒素EIA(C. Diff Quik Chek Complete;Techlab),GDH与毒素不一致样本用半定量细胞毒性中和试验(CCNA)仲裁。
- Clarity与标准算法不一致的样本用PCR(Xpert C. difficile;Cepheid)检测并进行病历回顾。
主要发现
- 测试算法得到34份GDH+/毒素+、53份GDH-/毒素-、124份GDH+/毒素-样本,其中39份CCNA+、85份CCNA-。
- Clarity与GDH-/毒素-样本阴性一致率96.2%,与GDH+/毒素+样本阳性一致率100%,与GDH+/毒素-/CCNA-样本一致率95.3%。
- 一份样本Clarity结果无效。
- Clarity与GDH+/毒素-/CCNA+样本一致率61.5%,其中高阳性样本一致率90.0%,低阳性样本一致率31.6%。
临床怎么用
- Clarity检测与GDH-毒素EIA联合CCNA算法高度一致,可能作为CDI诊断的独立自动化方案。
- 对GDH+/毒素-/CCNA+样本,尤其低阳性样本,Clarity一致率较低,需结合临床判断。
局限性
- 使用残余去标识粪便样本,样本在-80°C储存后检测。
- 为回顾性研究,需进一步前瞻性临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Singulex Clarity C. diff toxins A/B (Clarity) assay is an automated, ultrasensitive immunoassay for the detection of Clostridioides difficile toxins in stool. In this study, the performance of the Clarity assay was compared to that of a multistep algorithm using an enzyme immunoassay (EIA) for detection of glutamate dehydrogenase (GDH) and toxins A and B arbitrated by a semiquantitative cell cytotoxicity neutralization assay (CCNA). The performance of the assay was evaluated using 211 residual deidentified stool samples tested with a GDH-and-toxin EIA (C. Diff Quik Chek Complete; Techlab), with GDH-and-toxin discordant samples tested with CCNA. The stool samples were stored at -80°C before being tested with the Clarity assay. For samples discordant between Clarity and the standard-of-care algorithm, the samples were tested with PCR (Xpert C. difficile; Cepheid), and chart review was performed. The testing algorithm resulted in 34 GDH+/toxin+, 53 GDH-/toxin-, and 124 GDH+/toxin- samples, of which 39 were CCNA+ and 85 were CCNA- Clarity had 96.2% negative agreement with GDH-/toxin- samples, 100% positive agreement with GDH+/toxin+ samples, and 95.3% agreement with GDH+/toxin-/CCNA- samples. The Clarity result was invalid for one sample. Clarity agreed with 61.5% of GDH+/toxin-/CCNA+ samples, 90.0% of GDH+/toxin-/CCNA+ (high-positive) samples, and 31.6% of GDH+/toxin-/CCNA+ (low-positive) samples. The Singulex Clarity C. diff toxins A/B assay demonstrated high agreement with a testing algorithm utilizing a GDH-and-toxin EIA and CCNA. This novel automated assay may offer an accurate, stand-alone solution for C. difficile infection (CDI) diagnostics, and further prospective clinical studies are merited.
引用
- Landry ML, Topal JE, Estis J, et al. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing. J Clin Microbiol. 2020. PMID: 31776192. doi:10.1128/JCM.01629-19
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。